Chairman and CEO, Dr. Glynn Wilson, and COO, Dr John Bonfiglio, will speak with investors and advisors through an interactive real-time virtual conference on Thursday, February 2, 2017.

During the webinar, Dr. Bonfiglio and Dr. Wilson will focus on the company’s recent accomplishments and progress, especially surrounding its sponsored Phase 2 trial in triple-negative breast cancer now enrolling at nine sites and the status of the Phase 2 trial in triple negative breast cancer sponsored by the Mayo Clinic. They will also discuss their ongoing trial with Memorial Sloan Kettering and AstraZeneca in ovarian cancer.

Attendees are invited to ask them questions in real-time, both in the presentation hall as well as the association’s “virtual trade booth.” If attendees are not able to join the interactive online event live, an on-demand archive will be available for 90 days.

It is recommended that attendees pre-register and run the online system check to save time and receive event updates.

DATE: Thursday, February 2, 2017
TIME: 12:15 p.m. Eastern Time
LINK: http://tinyurl.com/201prepr

Leave a Reply

Your email address will not be published. Required fields are marked *

clear formPost comment